文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

Phoenixin-14减轻脓毒症诱导大鼠的氧化多器官损伤

Phoenixin-14 Attenuates Oxidative Multiorgan Damage in Sepsis-Induced Rats.
PubMed 文献 · Shock · 2026-06-09
一句话结论脓毒症大鼠模型中,PNX-14预处理减轻全身炎症和多器官氧化应激,而迷走神经刺激与PNX-14联用未产生叠加效应,部分情况下反而加重氧化损伤。

研究在盲肠结扎穿孔诱导的脓毒症雄性Sprague-Dawley大鼠中,评估Phoenixin-14(PNX-14,50 µg/kg/d,腹腔注射,4天)和/或经皮耳迷走神经刺激(VNS,20 Hz,30 min/d)的独立及联合抗炎作用,并探索PNX与nesfatin-1信号的关系。PNX-14预处理减轻脓毒症诱导的低体温,显著降低血清白细胞介素-6和肿瘤坏死因子-α水平,并逆转脑、心、肺和回肠的氧化损伤、恢复抗氧化水平。VNS单独提供适度保护(主要在心脏和肠道组织),但与PNX-14联用未产生叠加效应,部分情况下反而加重氧化损伤。组织病理学支持生化结果,免疫组化显示PNX和VNS均保留PNX和nesfatin-1表达。作者认为PNX-14是有前景的治疗候选,同时建议谨慎将其与神经调控策略联用。

要点

  • 脓毒症大鼠中,PNX-14预处理(50 µg/kg/d,腹腔注射,4天)减轻低体温并显著降低血清IL-6和TNF-α水平。
  • PNX-14逆转脑、心、肺和回肠的氧化损伤并恢复抗氧化水平,组织病理学显示组织损伤减轻。
  • VNS单独(20 Hz,30 min/d)提供适度保护,主要在心脏和肠道组织。
  • VNS与PNX-14联用未产生叠加效应,部分情况下反而加重氧化损伤,作者建议谨慎联用。
  • 免疫组化显示PNX和VNS均保留PNX和nesfatin-1表达;体外回肠条收缩力在VNS预处理脓毒症大鼠中改善。

适用人群与场景

  • 雄性Sprague-Dawley大鼠,盲肠结扎穿孔诱导的脓毒症模型;设假手术对照组。

处置流程与药物剂量

  • PNX-14预处理:50 µg/kg/d,腹腔注射,4天。
  • 经皮耳迷走神经刺激:20 Hz,30 min/d。
  • 盲肠结扎穿孔后第16小时采集组织和血清样本进行检测。

研究设计与关键结果

  • 研究类型:动物实验(大鼠),6个实验组,包括假手术对照组和脓毒症诱导组(有或无PNX-14和/或经皮耳迷走神经刺激预处理)。
  • PNX-14预处理减轻脓毒症诱导的低体温,显著降低血清白细胞介素-6和肿瘤坏死因子-α水平。
  • PNX-14逆转脑、心、肺和回肠的氧化损伤并恢复抗氧化水平(丙二醛、髓过氧化物酶活性、谷胱甘肽、超氧化物歧化酶、过氧化氢酶)。
  • VNS单独提供适度保护,主要在心脏和肠道组织;与PNX-14联用未产生叠加效应,部分情况下反而加重氧化损伤。
  • 组织病理学显示PNX减轻组织损伤;免疫组化显示PNX和VNS均保留PNX和nesfatin-1表达。
  • 体外回肠条收缩力在脓毒症诱导后降低,VNS预处理脓毒症大鼠的回肠条收缩力改善。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为PNX-14是有前景的治疗候选。
  • 作者建议谨慎将PNX-14与神经调控策略(如VNS)联用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is a critical clinical condition characterized by life-threatening multi-organ dysfunction resulting from a dysregulated host response to infection. This study evaluated the individual and combined anti-inflammatory effects of Phoenixin-14 (PNX-14) and vagus nerve stimulation (VNS), while exploring whether PNX interacts with nesfatin-1 signaling. Male Sprague-Dawley rats were assigned to six experimental groups, including sham-operated controls, and sepsis-induced groups with or without pretreatment with PNX-14 (50 µg/kg/day, i.p., 4 days) and/or transcutaneous auricular VNS (20 Hz, 30 min/day). Sepsis was induced using cecal ligation and puncture (CLP). At the 16th hour following CLP, tissue and serum samples were collected for assessment of proinflammatory cytokines (IL-6, TNF-α), oxidative stress markers (malondialdehyde, myeloperoxidase activity, glutathione, superoxide dismutase, catalase), histological changes, and immunohistochemical expression of PNX and nesfatin-1. Additionally, in vitro ileal contractility was evaluated. PNX-14 pretreatment attenuated sepsis-induced hypothermia and significantly reduced serum IL-6 and TNF-α levels. PNX-14 also reversed oxidative damage and restored antioxidant levels in the brain, heart, lung, and ileum. While VNS alone provided modest protection-primarily in cardiac and intestinal tissues-its combination with PNX-14 failed to produce additive effects and, in some instances, exacerbated oxidative damage. Histopathological findings supported the biochemical results, showing reduced tissue damage with PNX. Immunohistochemistry revealed that both PNX and VNS preserved PNX and nesfatin-1 expression. In vitro, reduced contractility of ileal strips due to sepsis induction was improved when the septic rats were pretreated with VNS. PNX-14 exerts potent protective effects against systemic inflammation and multi-organ oxidative stress in sepsis. Notably, VNS does not enhance PNX-14 efficacy and may interfere with its protective mechanisms. These findings highlight PNX-14 as a promising therapeutic candidate, while suggesting caution in combining it with neuromodulatory strategies.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Özdemir Kumral ZN, Şen LS, Çantali-Öztürk Ç, et al. Phoenixin-14 attenuates oxidative multi-organ damage in sepsis-induced rats. Shock. 2026. PMID: 42262981. doi:10.1097/SHK.0000000000002888

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。